1
项与 Anti-CD19 CAR-T cell therapy(Bioceltech Therapeutics Ltd) 相关的临床试验Phase I Study of the Safety and Efficacy of CD19-CAR-T Cells in Patients With Relapsed or Refractory Acute B-cell Lymphoblastic Leukemia (R/R B-ALL)
This is a single center, single arm, open-lable phase 1 study to determine the safety and efficacy of autologous or donor-derived allogeneic T cells expressing CD19 chimeric antigen receptors (referred to as "CD19-CAR-T cells") in patients with relapsed or refractory acute B-cell lymphoblastic leukemia (R/R B-ALL).
100 项与 Anti-CD19 CAR-T cell therapy(Bioceltech Therapeutics Ltd) 相关的临床结果
100 项与 Anti-CD19 CAR-T cell therapy(Bioceltech Therapeutics Ltd) 相关的转化医学
100 项与 Anti-CD19 CAR-T cell therapy(Bioceltech Therapeutics Ltd) 相关的专利(医药)
100 项与 Anti-CD19 CAR-T cell therapy(Bioceltech Therapeutics Ltd) 相关的药物交易